<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00951197</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX2008/13</org_study_id>
    <nct_id>NCT00951197</nct_id>
  </id_info>
  <brief_title>Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects</brief_title>
  <acronym>AMIMAGE</acronym>
  <official_title>Estimation of Microstructure Alteration by MRI in Dementia Among Elderly Subjects Retired From Agricultural Profession and Living in Rural Area in Gironde - Participants From the AMI Cohort.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Capturing the earliest stages of Dementia especially Alzheimer's Disease (AD) is a great
      challenge. Until now the NINCDS-ADRDA and the DSM criteria for AD were largely used as
      diagnostic standards in research. However, the research on AD progresses and some biomarkers
      have been recently suggested to improve the diagnostic criteria of AD, such as cerebrospinal
      fluid markers, neuroimaging with Positon Emission Tomography (PET) or Magnetic Resonance
      Imaging (MRI).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>FA (Fractional Anisotropy), MTR (magnetization transfer ratio) and T2 (Transverse relaxation time) measures in patients with dementia compared to controls, in left and right hippocampus, and posterior cingulum</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>FA, MTR and T2 measures in subjects with mild cognitive impairment no dementia</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performances in the 7 neuropsychological tests available in the AMI cohort</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FA measures for the connexion Hippocampus-cingulum posterior</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">318</enrollment>
  <condition>Dementia</condition>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>elderly subjects retired from agriculture</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuroimaging</intervention_name>
    <description>Three successive MRI acquisitions to measure FA, MTR and T2 parameters.</description>
    <arm_group_label>elderly subjects retired from agriculture</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        population retired from agricultural profession and living in rural area in Gironde
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  participate in the AMI cohort

          -  be aged 65 and older

          -  be retired from agricultural profession

          -  live in rural area in Gironde

        Exclusion Criteria:

          -  contraindication of MRI

          -  left-handed

          -  severe dementia

          -  Parkinson's disease

          -  poor health incompatible with the transport to neuroimaging service

          -  to be left handed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mich√®le ALLARD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Pellegrin - C.H.U. de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2009</study_first_submitted>
  <study_first_submitted_qc>August 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2009</study_first_posted>
  <last_update_submitted>April 27, 2012</last_update_submitted>
  <last_update_submitted_qc>April 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dementia</keyword>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>diagnostic</keyword>
  <keyword>biomarkers</keyword>
  <keyword>neuroimaging</keyword>
  <keyword>PET</keyword>
  <keyword>MRI</keyword>
  <keyword>mild cognitive impairment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

